Back to top
more

Sensus Healthcare (SRTS)

(Delayed Data from NSDQ)

$6.35 USD

6.35
185,080

-0.07 (-1.09%)

Updated Jul 24, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (103 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

Sensus Healthcare (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why

Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know

Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $6.42, moving -0.47% from the previous trading session.

Shrabana Mukherjee headshot

3 Stocks in Focus as New Analysts Initiate Coverage

The recent surge in analyst coverage for stocks such as BrightSphere (BSIG), Sensus Healthcare (SRTS) and ServisFirst (SFBS) indicates the potential for significant price appreciation in the near term.

Sensus Healthcare (SRTS) Upgraded to Buy: What Does It Mean for the Stock?

Sensus Healthcare (SRTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?

Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.

Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors

Sensus Healthcare, Inc. (SRTS) closed at $5.99 in the latest trading session, marking a -0.66% move from the prior day.

Sensus Healthcare (SRTS) Is a Great Choice for 'Trend' Investors, Here's Why

Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Sensus Healthcare, Inc. (SRTS) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.87, marking a -1.81% move from the previous day.

Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors

Sensus Healthcare, Inc. (SRTS) closed at $5.22 in the latest trading session, marking a -1.51% move from the prior day.

Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade

Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $5.48, signifying a -0.54% move from its prior day's close.

Sensus Healthcare, Inc. (SRTS) Crossed Above the 20-Day Moving Average: What That Means for Investors

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Here's Why Momentum in Sensus Healthcare (SRTS) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year?

Here is how Sensus Healthcare, Inc. (SRTS) and Aileron Therapeutics, Inc. (ALRN) have performed compared to their sector so far this year.

Zacks.com featured highlights include Sensus Healthcare, Diebold Nixdorf, Adtalem Global Education, Dycom Industries and Superior Group

Sensus Healthcare, Diebold Nixdorf, Adtalem Global Education, Dycom Industries and Superior Group are part of the Zacks Screen of the Week article.

Nalak Das headshot

5 Stocks With Recent Price Strength That Have More Upside Left

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SRTS, DBD, ATGE, DY, SGC.

Here's What Could Help Sensus Healthcare (SRTS) Maintain Its Recent Price Strength

Sensus Healthcare (SRTS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?

Integer (ITGR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

New Strong Buy Stocks for February 12th

MSGE, AZEK, XRX, AMSC and SRTS have been added to the Zacks Rank #1 (Strong Buy) List on February 12, 2023.

Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 116.67% and 3.89%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline

Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?

Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 60% and 7.69%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Sensus Healthcare (SRTS) Expands Global Base With New Pact

The agreement includes the distribution of Sensus Healthcare's (SRTS) SRT-100, SRT-100+ and SR-100 Vision systems, specifically designed for the treatment of non-melanoma skin cancer and keloids.

CVRx (CVRX) Surges 7.2%: Is This an Indication of Further Gains?

CVRx (CVRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.